Hospital management company Universal Health Services (NYSE:UHS) will be announcing earnings results tomorrow after market close. Here’s what to expect.

Universal Health Services beat analysts’ revenue expectations by 2.6% last quarter, reporting revenues of $4.11 billion, up 11.1% year on year. It was a very strong quarter for the company, with a solid beat of analysts’ full-year EPS guidance estimates.

Is Universal Health Services a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Universal Health Services’s revenue to grow 8% year on year to $4.15 billion, slowing from the 10.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $4.35 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Universal Health Services has missed Wall Street’s revenue estimates twice over the last two years.

Looking at Universal Health Services’s peers in the healthcare providers & services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. HCA Healthcare delivered year-on-year revenue growth of 5.7%, beating analysts’ expectations by 0.5%, and Centene reported revenues up 15.4%, topping estimates by 8.3%.

Read our full analysis of HCA Healthcare’s results here and Centene’s results here.

Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 5.6% on average over the last month. Universal Health Services is down 7.7% during the same time and is heading into earnings with an average analyst price target of $224.59 (compared to the current share price of $173.50).

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.